News
Leo Lens Pharma Achieves Two Significant Milestones – FDA IND Submission and Seed Round Fundraising Success
IND Paves the Way to Phase 2a Clinical Study and Seed Round Lead Advances Company’s Efforts for Its Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire, November 12th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based
Leo Lens Pharma Expands Its Scientific Advisory Board
External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion
Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
Patented product for the novel treatment of glaucoma is IND-ready FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (BUSINESS WIRE June 23, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, is pleased to announce that its lead asset,